Cargando…

AMPK and Polycystic Kidney Disease Drug Development: An Interesting Off-Target Target

Autosomal Dominant Polycystic Kidney Disease is a genetic disease that causes dramatic perturbations of both renal tissue architecture and of a multitude of cellular signaling pathways. The relationship between the products of the genes whose mutations cause polycystic kidney disease and these signa...

Descripción completa

Detalles Bibliográficos
Autor principal:	Caplan, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841847/ https://www.ncbi.nlm.nih.gov/pubmed/35174190 http://dx.doi.org/10.3389/fmed.2022.753418

Ejemplares similares

The cell biology of polycystic kidney disease
por: Chapin, Hannah C., et al.
Publicado: (2010)

Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease
por: Iliuta, Ioan-Andrei, et al.
Publicado: (2022)

AMPK: Potential Therapeutic Target for Vascular Calcification
por: Lu, Yi, et al.
Publicado: (2021)

Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2022)

Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Vendramini, Larissa Collis, et al.
Publicado: (2019)

High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease
por: Booij, Tijmen H., et al.
Publicado: (2017)

The Importance of Radiologic Imaging Modalities in Autosomal Dominant Polycystic Kidney Disease
por: Nadal Bosch, Jorge, et al.
Publicado: (2022)

Polycystic Kidney Disease Drug Development: A Conference Report
por: Liebau, Max C., et al.
Publicado: (2022)

Exceptionally Large Kidneys in Autosomal Dominant Polycystic Disease in India
por: Shiza, Saher T, et al.
Publicado: (2021)

Complement, a Therapeutic Target in Diabetic Kidney Disease
por: Budge, Kelly, et al.
Publicado: (2021)

Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease
por: Zheng, Qi, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules
por: Tarasiuk, Olga, et al.
Publicado: (2022)

Polycystic kidney diseases: From molecular discoveries to targeted therapeutic strategies
por: Ibraghimov-Beskrovnaya, O., et al.
Publicado: (2007)

Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease
por: Weimbs, Thomas, et al.
Publicado: (2018)

Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
por: Bais, Thomas, et al.
Publicado: (2022)

Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
por: Griffiths, Joshua, et al.
Publicado: (2020)

Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease
por: Yu, Jianwen, et al.
Publicado: (2021)

Detection of Autosomal Dominant Polycystic Kidney Disease by Medical Checkup at an Early Stage
por: Fukunaga, Shohei, et al.
Publicado: (2021)

The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome
por: Biernacka-Bartnik, Aleksandra, et al.
Publicado: (2023)

A Rare Case of Pelvic Organ Prolapse in a Nulliparous Female With Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Polycystic Liver Disease (PLD)
por: Hechter, Sharon, et al.
Publicado: (2021)

Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
por: Kim, Hyun-Jung, et al.
Publicado: (2012)

Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment
por: Haumann, Sophie, et al.
Publicado: (2020)

Modeling Pkd1 gene-targeted strategies for correction of polycystic kidney disease
por: Kurbegovic, Almira, et al.
Publicado: (2023)

Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease
por: Naranjo, Javier, et al.
Publicado: (2022)

Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants
por: Daneshgar, Nastaran, et al.
Publicado: (2021)

Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership
por: Harris, Tess, et al.
Publicado: (2022)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Mosaic PKHD1 in Polycystic Kidneys Caused Aberrant Protein Expression in the Mitochondria and Lysosomes
por: Xu, Chengxian, et al.
Publicado: (2021)

In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease
por: Cox, Alysia, et al.
Publicado: (2023)

Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies
por: Eikmans, Michael, et al.
Publicado: (2019)

Production Cross-Section Measurements for Terbium Radionuclides of Medical Interest Produced in Tantalum Targets Irradiated by 0.3 to 1.7 GeV Protons and Corresponding Thick Target Yield Calculations
por: Duchemin, Charlotte, et al.
Publicado: (2021)

Using RNA-based therapies to target the kidney in cardiovascular disease
por: Palmer, Trecia C., et al.
Publicado: (2023)

Development of a human malaria-on-a-chip disease model for drug efficacy and off-target toxicity evaluation
por: Rupar, Michael J., et al.
Publicado: (2023)

Targeted Needs Assessment of Off-service Residents in Emergency Medicine
por: Kessler, Chad S., et al.
Publicado: (2010)

Identifying the Right Target for New Drugs in Acute Kidney Injury: A Long Way Off?
por: Doi, Kent
Publicado: (2023)

Safety and Tolerability of Tolvaptan in an Autosomal Dominant Polycystic Kidney Disease Spanish Cohort: A Real-World Experience
por: Guerra-Torres, Xavier E, et al.
Publicado: (2020)

Autosomal dominant polycystic kidney disease: a potential mistake in the interpretation of radioiodine whole-body scintigraphy
por: Kalhor, Leila
Publicado: (2018)

Conned by Conn’s: The Manifestation of Conn’s Syndrome Post-renal Transplant in a Patient with Polycystic Kidney Disease
por: Rojulpote, Chaitanya, et al.
Publicado: (2020)

An Unexpected Association of Primary Biliary Cholangitis in a Male Patient With Autosomal Dominant Polycystic Kidney Disease
por: Jaramillo, Patricio A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5qg3es4n11hd06hev74e3lmst4